title: Identification of novel genes responsible for overexpression of ampC in Pseudomonas aeruginosa PAO1.
abstract: The development of resistance to antipseudomonal penicillins and cephalosporins mediated by the chromosomal ampC gene in Pseudomonas aeruginosa is of clinical importance. We isolated piperacillin-resistant mutants derived from P. aeruginosa PAO1 and analyzed two mutants that had an insertion in mpl and nuoN. One mutant, YT1677, was resistant to piperacillin and ceftazidime and had an insertion in mpl, which encodes UDP-N-acetylmuramate:l-alanyl-γ-d-glutamyl-meso-diaminopimelate ligase. The other mutant, YT7988, showed increased MICs of piperacillin, ceftazidime, cefepime, and cefoperazone, and the insertion was mapped to nuoN, which encodes NADH dehydrogenase I chain N. Complementation experiments demonstrated that these mutations resulted in higher levels of resistance to β-lactams. The expression of genes reported to be involved in β-lactam resistance was examined by real-time PCR in YT1677 and YT7988 mutants. Overexpression was observed for only ampC, and other genes were expressed normally. Deletion of the ampR gene in YT1677 and YT7988 resulted in decreased expression of ampC, indicating that the mutations in YT1677 and YT7988 affected the expression of ampC through the function of AmpR.
authors.affiliation: Department of Bacteriology.
authors.forename: Yuko
authors.initials: Y
authors.lastname: Tsutsumi
authors.forename: Haruyoshi
authors.initials: H
authors.lastname: Tomita
authors.forename: Koichi
authors.initials: K
authors.lastname: Tanimoto
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001426:Bacterial Proteins / Q000235:genetics* / Q000378:metabolism; D042967:Electron Transport Complex I / Q000235:genetics* / Q000378:metabolism; D015964:Gene Expression Regulation, Bacterial; D005816:Genetic Complementation Test; D008826:Microbial Sensitivity Tests; D016254:Mutagenesis, Insertional; D010453:Peptide Synthases / Q000235:genetics* / Q000378:metabolism; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000201:enzymology / Q000235:genetics*; D018440:beta-Lactam Resistance / Q000235:genetics; D001618:beta-Lactamases / Q000235:genetics* / Q000378:metabolism; D047090:beta-Lactams / Q000494:pharmacology
chemical_list: D000900:Anti-Bacterial Agents; D001426:Bacterial Proteins; D047090:beta-Lactams; C071526:AmpR protein, Bacteria; C048795:AmpC beta-lactamases; D001618:beta-Lactamases; D010453:Peptide Synthases; C049145:UDP-N-acetylmuramoylalanyl-D-glutamate-2,6-diaminopimelate ligase; D042967:Electron Transport Complex I
references.citation: Biotechniques. 2000 Nov;29(5):948-50, 952
references.pmid: 11084852
references.citation: Clin Microbiol Rev. 2005 Apr;18(2):306-25
references.pmid: 15831827
references.citation: PLoS Pathog. 2009 Mar;5(3):e1000353
references.pmid: 19325877
references.citation: Clin Microbiol Rev. 2007 Jan;20(1):79-114
references.pmid: 17223624
references.citation: Antimicrob Agents Chemother. 2007 Mar;51(3):1016-21
references.pmid: 17194835
references.citation: Antimicrob Agents Chemother. 2010 Sep;54(9):3557-63
references.pmid: 20566764
references.citation: Clin Microbiol Rev. 2009 Jan;22(1):161-82, Table of Contents
references.pmid: 19136439
references.citation: Nature. 2000 Aug 31;406(6799):959-64
references.pmid: 10984043
references.citation: Antimicrob Agents Chemother. 1998 Dec;42(12):3296-300
references.pmid: 9835532
references.citation: Gene. 1998 May 28;212(1):77-86
references.pmid: 9661666
references.citation: Antimicrob Agents Chemother. 2006 May;50(5):1780-7
references.pmid: 16641450
references.citation: Antimicrob Agents Chemother. 2000 Mar;44(3):583-9
references.pmid: 10681322
references.citation: EMBO J. 1994 Oct 3;13(19):4684-94
references.pmid: 7925310
references.citation: J Biol Chem. 2001 Jul 20;276(29):26955-61
references.pmid: 11350954
references.citation: Antimicrob Agents Chemother. 2005 Mar;49(3):1145-9
references.pmid: 15728916
references.citation: Antimicrob Agents Chemother. 2006 Nov;50(11):3562-7
references.pmid: 16940057
references.citation: Proc Natl Acad Sci U S A. 1979 Apr;76(4):1648-52
references.pmid: 377280
references.citation: Plasmid. 2004 May;51(3):246-55
references.pmid: 15109831
references.citation: Antimicrob Agents Chemother. 1995 Jun;39(6):1211-33
references.pmid: 7574506
references.citation: Antimicrob Agents Chemother. 2012 Dec;56(12):6349-57
references.pmid: 23045355
references.citation: J Microbiol Methods. 2010 Sep;82(3):205-13
references.pmid: 20538017
references.citation: Antimicrob Agents Chemother. 2009 Jun;53(6):2274-82
references.pmid: 19273679
references.citation: Antimicrob Agents Chemother. 2005 Nov;49(11):4567-75
references.pmid: 16251297
references.citation: J Bacteriol. 1987 May;169(5):1923-8
references.pmid: 3032901
references.citation: J Bacteriol. 1996 Sep;178(18):5347-52
references.pmid: 8808921
references.citation: Biochem J. 1991 May 15;276 ( Pt 1):269-70
references.pmid: 2039479
references.citation: Mol Microbiol. 1993 Aug;9(4):703-15
references.pmid: 8231804
references.citation: Appl Environ Microbiol. 1998 Jul;64(7):2710-5
references.pmid: 9647854
references.citation: Microbiol Mol Biol Rev. 2008 Jun;72(2):211-27, table of contents
references.pmid: 18535144
references.citation: FEMS Microbiol Lett. 2006 Jan;254(2):217-25
references.pmid: 16445748
references.citation: EMBO J. 1986 Dec 20;5(13):3709-14
references.pmid: 3030737
references.citation: EMBO J. 1982;1(7):875-81
references.pmid: 6329713
references.citation: Antimicrob Agents Chemother. 2010 May;54(5):2219-24
references.pmid: 20194693
references.citation: Clin Microbiol Rev. 2009 Oct;22(4):582-610
references.pmid: 19822890
references.citation: Antimicrob Agents Chemother. 2008 Oct;52(10):3795-800
references.pmid: 18694945